75 related articles for article (PubMed ID: 38651453)
1. A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia.
Candoni A; Coppola G
Hematol Rep; 2024 Apr; 16(2):244-254. PubMed ID: 38651453
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression.
Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM
Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Menin Inhibitors: Novel Therapeutic Agents Targeting Acute Myeloid Leukemia with KMT2A Rearrangement or NPM1 Mutation.
Thomas X
Oncol Ther; 2024 Mar; 12(1):57-72. PubMed ID: 38300432
[TBL] [Abstract][Full Text] [Related]
4. Targeting the undruggable: menin inhibitors ante portas.
Dempke WCM; Desole M; Chiusolo P; Sica S; Schmidt-Hieber M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9451-9459. PubMed ID: 37103568
[TBL] [Abstract][Full Text] [Related]
5. Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?
Swaminathan M; Bourgeois W; Armstrong SA; Wang ES
Cancer J; 2022 Jan-Feb 01; 28(1):62-66. PubMed ID: 35072375
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effects of the RAR
Fleischmann M; Bechwar J; Voigtländer D; Fischer M; Schnetzke U; Hochhaus A; Scholl S
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610989
[TBL] [Abstract][Full Text] [Related]
7. Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction.
Wolffhardt TM; Ketzer F; Telese S; Wirth T; Ushmorov A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003662
[TBL] [Abstract][Full Text] [Related]
8. Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024.
Buchrits S; Wolach O
Acta Haematol; 2024; 147(2):159-174. PubMed ID: 37906979
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.
Barajas JM; Rasouli M; Umeda M; Hiltenbrand R; Abdelhamed S; Mohnani R; Arthur B; Westover T; Thomas ME; Ashtiani M; Janke LJ; Xu B; Chang TC; Rosikiewicz W; Xiong E; Rolle C; Low J; Krishan R; Song G; Walsh MP; Ma J; Rubnitz JE; Iacobucci I; Chen T; Krippner-Heidenreich A; Zwaan CM; Heidenreich O; Klco JM
Blood; 2024 Feb; 143(7):619-630. PubMed ID: 37890156
[TBL] [Abstract][Full Text] [Related]
10. Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid Leukemia.
Premnath N; Madanat YF
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296920
[TBL] [Abstract][Full Text] [Related]
11. Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with
Rausch J; Dzama MM; Dolgikh N; Stiller HL; Bohl SR; Lahrmann C; Kunz K; Kessler L; Echchannaoui H; Chen CW; Kindler T; Döhner K; Burrows F; Theobald M; Sasca D; Kühn MWM
Haematologica; 2023 Oct; 108(10):2837-2843. PubMed ID: 37102614
[No Abstract] [Full Text] [Related]
12. Acute myeloid leukaemia.
DiNardo CD; Erba HP; Freeman SD; Wei AH
Lancet; 2023 Jun; 401(10393):2073-2086. PubMed ID: 37068505
[TBL] [Abstract][Full Text] [Related]
13. MEN1 mutations mediate clinical resistance to menin inhibition.
Perner F; Stein EM; Wenge DV; Singh S; Kim J; Apazidis A; Rahnamoun H; Anand D; Marinaccio C; Hatton C; Wen Y; Stone RM; Schaller D; Mowla S; Xiao W; Gamlen HA; Stonestrom AJ; Persaud S; Ener E; Cutler JA; Doench JG; McGeehan GM; Volkamer A; Chodera JD; Nowak RP; Fischer ES; Levine RL; Armstrong SA; Cai SF
Nature; 2023 Mar; 615(7954):913-919. PubMed ID: 36922589
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
